Use of aminothiolester derivatives in pharmaceutics
US6028114A · kind A · utility
8Cited by
1References
19Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | May 25, 1999 |
| Grant date | Feb 22, 2000 |
| Priority date | — |
| Expiry date | May 25, 2019 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Use of at least one aminothiol ester derivative for the preparation of a pharmaceutical composition intended to increase the inhibition of a character resistant to the induction of apoptosis of transformed cells, this character being due to the bc12 gene present in these cells. The pharmaceutical composition is more particularly intended to treat pathologies chosen from breast cancers, B cell lymphomas, leukaemias, neuroblastomas, adenocarcinomas of the prostate, prolactinomas and other pituitary adenomas.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.